Types of Cancer We Treat

Basal & Squamous Cell Skin Cancers in Adults

We established one of the first treatment programs in the New York City area for basal and squamous cell cancers, also called nonmelanoma skin cancers. Our dermatologists’ expertise in identifying and removing precancerous growths helps prevent many of these skin cancers from developing. When cancer is diagnosed, our medical oncologists, surgical oncologists, and radiation oncologists work together to provide the most effective treatment. Our reconstructive surgeons and rehabilitation doctors may also play an important role in your care.

Meet Our Doctors
Medical Oncologist Dr. Anna Pavlick
Diagnosis
Diagnosing Basal and Squamous Cell Skin Cancers in Adults
Therapies for Precancerous or Early Skin Cancer
Therapies for Precancerous or Early Basal and Squamous Cell Skin Cancers in Adults
Surgical Procedures
Surgical Procedures for Basal and Squamous Cell Skin Cancers in Adults
Medication
Medications for Basal and Squamous Cell Skin Cancers in Adults
Radiation Therapy
Radiation Therapy for Basal and Squamous Cell Skin Cancers in Adults

Related News

Expert Discusses Taking Care of Your Skin This Summer
Read Story

Clinical Trials and Research Studies

Phase 2

A Phase 2 Study of REGN2810 a Fully Human Monoclonal Antibody to Programmed Death-1 in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor therapy

Learn More

Phase 1

A Phase 1 b Study of the Selective HDAC Inhibitor Mocetinostat in Combination with Ipilimumab and Nivolumab in Patients with Unresectable Stage III or Stage IV Melanoma

Learn More

Phase 1

A Phase 1 First-in-Human Open Label Dose Escalation Study of MGD009 A Humanized B7-H3 x CD3 Dual-Affinity Re-Targeting (DART ) Protein in Patients with Unresectable or Metastatic B7-H3-Expressing Neoplasms and Neoplasms whose Vasculature Expresses

Learn More

Phase N/A

A prospective multi-site trial of a point of care saliva based detection test based on soluble CD44 (OncAlert) for presence of disease in previously untreated oral cavity and oropharynx squamous cell carcinoma.

Learn More
View All Related Clinical Trials (6)